NOD1 agonists as therapeutics for autoimmune disease (Q233292)

From EU Knowledge Graph
Jump to navigation Jump to search
Project Q233292 in Ireland
Language Label Description Also known as
English
NOD1 agonists as therapeutics for autoimmune disease
Project Q233292 in Ireland

    Statements

    country
    Ireland
    0 references
    EU contribution
    94,321.06 Euro
    0 references
    budget
    188,642.12 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    1 April 2015
    0 references
    end time
    1 April 2018
    0 references
    beneficiary name (string)
    Trinity College Dublin
    0 references
    summary
    NOD1 agonists as therapeutics for autoimmune disease (English)
    readability score
    0.0034859009920396
    0 references
    Agonistes NOD1 comme thérapeutiques pour les maladies auto-immunes (French)
    point in time
    25 November 2021
    0 references
    NOD1-Agonisten als Therapeutika für Autoimmunerkrankungen (German)
    point in time
    25 November 2021
    0 references
    NOD1 agonisten als therapieën voor auto-immuunziekte (Dutch)
    point in time
    27 November 2021
    0 references
    NOD1 agonisti come terapie per le malattie autoimmuni (Italian)
    point in time
    11 January 2022
    0 references
    Agonistas de NOD1 como terapias para la enfermedad autoinmune (Spanish)
    point in time
    12 January 2022
    0 references
    Agonists NOD1 mar theiripeach do ghalar autoimmune (Irish)
    point in time
    24 January 2022
    0 references
    NOD1 αγωνιστές ως θεραπευτικά μέσα για αυτοάνοση νόσο (Greek)
    point in time
    17 August 2022
    0 references
    NOD1-agonister som behandlingsmidler mod autoimmun sygdom (Danish)
    point in time
    17 August 2022
    0 references
    NOD1-agonistit autoimmuunitaudin hoitoon (Finnish)
    point in time
    17 August 2022
    0 references
    Agonisti NOD1 bħala terapewtiċi għal mard awtoimmuni (Maltese)
    point in time
    17 August 2022
    0 references
    NOD1 agonisti kā terapijas līdzekļi autoimūnai slimībai (Latvian)
    point in time
    17 August 2022
    0 references
    NOD1 agonisty ako terapeutické lieky na autoimunitné ochorenie (Slovak)
    point in time
    17 August 2022
    0 references
    Agonisté NOD1 jako terapeuti pro autoimunitní onemocnění (Czech)
    point in time
    17 August 2022
    0 references
    Agonistas NOD1 como terapêutica para doenças autoimunes (Portuguese)
    point in time
    17 August 2022
    0 references
    NOD1 agonistid autoimmuunhaiguse raviks (Estonian)
    point in time
    17 August 2022
    0 references
    NOD1 agonisták az autoimmun betegség terápiájaként (Hungarian)
    point in time
    17 August 2022
    0 references
    NOD1 агонисти като терапевтични средства за автоимунно заболяване (Bulgarian)
    point in time
    17 August 2022
    0 references
    NOD1 agonistai kaip terapiniai vaistai autoimuninei ligai gydyti (Lithuanian)
    point in time
    17 August 2022
    0 references
    NOD1 agonisti kao terapeuti za autoimunu bolest (Croatian)
    point in time
    17 August 2022
    0 references
    NOD1-agonister som terapeutiska medel för autoimmun sjukdom (Swedish)
    point in time
    17 August 2022
    0 references
    Agoniștii NOD1 ca tratamente pentru boala autoimună (Romanian)
    point in time
    17 August 2022
    0 references
    Agonisti NOD1 kot terapevti za avtoimunsko bolezen (Slovenian)
    point in time
    17 August 2022
    0 references
    Agoniści NOD1 jako leczenie chorób autoimmunologicznych (Polish)
    point in time
    17 August 2022
    0 references

    Identifiers

    Irish Koesio Identifier
    222
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q233292&oldid=42818019"